Common anti-platelet therapies modulate procoagulant phospholipids in arterial disease
Majd Protty(Institute of Infection and Immunity), Valerie B. O’Donnell(Cardiff University), Anirban Choudhury(Swansea Bay University Health Board), Alastair W. Poole(University of Bristol), Peter W. Collins(Institute of Infection and Immunity), Rito Mitra(University Hospital of Wales), David C. Bosanquet(Cardiff and Vale University Health Board), Ali A Hajeyah(Cardiff University), Yong Li(Central South University), Zaheer Yousef(University Hospital of Wales), Bethan Morgan(Cardiff University), Victoria J. Tyrrell(Cardiff University)
Cited by 1
Related Papers
The Fc receptor γ‐chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen
|The EMBO Journal|1997|448
Systematic Review and Meta-Regression of Factors Affecting Midline Incisional Hernia Rates: Analysis of 14 618 Patients
|PLoS ONE|2015|385
The use of viscoelastic haemostatic assays in the management of major bleeding
|British Journal of Haematology|2018|220
Wound bed preparation: <scp>TIME</scp> for an update
|International Wound Journal|2016|206
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
|Frontiers in Pharmacology|2022|187